Eagle Bay Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-710	Closed	-$2.08K	–	116
2024 Q4	$2.08K	Hold	710	–	–	﹤0.01%	871
2024 Q3	$1.85K	Hold	710	–	–	﹤0.01%	1241
2024 Q2	$2.1K	Hold	710	–	–	﹤0.01%	880
2024 Q1	$3.22K	Hold	710	–	–	﹤0.01%	819
2023 Q4	$4.05K	Hold	710	–	–	﹤0.01%	668
2023 Q3	$3.27K	Hold	710	–	–	﹤0.01%	720
2023 Q2	$4.59K	Buy	710 +355	+100%	+$2.42K	﹤0.01%	679
2023 Q1	$2.68K	Hold	355	–	–	﹤0.01%	730
2022 Q4	$3.6K	Sell	355 -900	-72%	-$10.4K	﹤0.01%	707
2022 Q3	$12K	Hold	1,255	–	–	0.01%	571
2022 Q2	$13.4K	Buy	+1,255	New	+$10.6K	0.01%	606
2022 Q1	–	Sell	-4,463	Closed	-$85K	–	294
2021 Q4	$85K	Buy	4,463 +1,363	+44%	+$20.7K	0.06%	222
2021 Q3	$62K	Buy	3,100 +1,300	+72%	+$23K	0.04%	344
2021 Q2	$40K	Buy	+1,800	New	+$49.6K	0.03%	391